Predictors of an increased in vitro thrombotic and bleeding tendency in critically ill trauma and non-trauma patients

Anaesthesia and Intensive Care

Volumn 43, Issue 3, 2015, Pages 317-322

  Ho, K M ^a,b   Duff, O C ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Assessment; Bleeding; Coagulation; Injury; Thrombosis

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; HEPARIN;

ADULT; ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING TEST; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; IN VITRO STUDY; INJURY; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PREDICTOR VARIABLE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; VENOUS THROMBOEMBOLISM; BLOOD; BLOOD COAGULATION DISORDERS; CRITICAL ILLNESS; HEMORRHAGE; INTENSIVE CARE; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK; STATISTICS AND NUMERICAL DATA; THROMBOSIS; YOUNG ADULT;

ADULT; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HEMORRHAGE; HUMANS; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK; THROMBELASTOGRAPHY; THROMBOCYTOPENIA; THROMBOSIS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84929714334     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1504300306     Document Type: Article

References (20)

1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:7S-47S.
2. Kakkar AK, Davidson BL, Haas SK, Investigators Against Thromboembolism (INATE) Core Group. Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. J Thromb Haemost 2004; 2:221-227.
3. Ginzburg E, Dujardin F. Physicians' perceptions of the definition of major bleeding in major orthopedic surgery: results of an international survey. J Thromb Thrombolysis 2011; 31:188-195.
4. Nathens AB, McMurray MK, Cuschieri J, Durr EA, Moore EE, Bankey PE et al. The practice of venous thromboembolism prophylaxis in the major trauma patient. J Trauma 2007; 62:557-562.
5. Schultz DJ, Brasel KJ, Washington L, Goodman LR, Quickel RR, Lipchik RJ et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma 2004; 56:727-731.
6. Ho KM, Tan JA. Stratified meta-analysis of intermittent pneumatic compression of the lower limbs to prevent venous thromboembolism in hospitalized patients. Circulation 2013; 128:1003-1020.
7. Bandle J, Shackford SR, Sise CB, Knudson MM, CLOTT Study Group. Variability is the standard: the management of venous thromboembolic disease following trauma. J Trauma Acute Care Surg 2014; 76:213-216.
8. Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth 2010; 105:596-602.
9. Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. Chest 2011; 140:1436-1446.
10. Koliscak L, Maynor L. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies. Am J Health Syst Pharm 2012; 69:658-663.
11. Al-Dorzi HM, Tamim HM, Aldawood AS, Arabi YM. Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis 2013; 2013:807526.
12. Gibbs NM. Hypocoagulability, hypercoagulability and the interpretation of 'normal' kaolin-activated thrombelastographs in the perioperative period. Anaesth Intensive Care 2011; 39:802-803.
13. Tripodi A, Chantarangkul V, Mannucci PM. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009; 147:77-82.
14. Ho KM, Tan JA. Can the presence of significant coagulopathy be useful to exclude symptomatic acute pulmonary embolism? Anaesth Intensive Care 2013; 41:322-327.
15. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15:R108.
16. Desborough MJ, Stanworth SJ. Uses and abuses of freshfrozen plasma for the prophylaxis of bleeding. Clin Med 2013; 13:197-199.
17. Louis SG, Van PY, Riha GM, Barton JS, Kunio NR, Underwood SJ et al. Thromboelastogram-guided enoxaparin dosing does not confer protection from deep venous thrombosis: a randomized controlled pilot trial. J Trauma Acute Care Surg 2014; 76:937-942.
18. Hagemo JS, Stanworth S, Juffermans NP, Brohi K, Cohen M, Johansson PI et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicentre observational study. Crit Care 2014; 18: R52.
19. Duff OC, Ho KM, Maybrook S. In-vitro thrombotic tendency of reactive thrombocytosis in critically ill patients: a prospective case-control study. Anaesth Intensive Care 2012; 40:472-478.
20. Ho KM, Yip CB, Duff O. Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study. J Thromb Haemost 2012; 10:1768-1774.